introduction ischemic heart disease ihd leading cause global mortality among top cause morbidity responsible million death worldwide loss million disability-adjusted life year http preventive treatment including lifestyle modification pharmacologic intervention e.g. cholesterol-lowering medication guided risk assessment framingham coronary heart disease risk score pooled cohort equation pce commonly utilized risk estimation method ihd atherosclerotic cardiovascular disease respectively demographic risk factor cholesterol value predict 10-year ihd risk individual aged 30–74 year old without known ihd baseline examination pce developed model 10-year risk major atherosclerotic cardiovascular disease event including fatal nonfatal ihd well fatal nonfatal stroke risk score used standard ihd risk assessment current clinical practice guideline policy recommendation including recent american college cardiology/american heart association guideline primary prevention cardiovascular disease validation risk score shown varying performance depending subpopulation analyzed performance typically reported c-statistic value corresponds proportion case–control pair higher risk assigned case measure discrimination previously reported c-statistic value pce modest typical range 0.66–0.76 0.68–0.76 respectively leaving potential room improvement thus discovery additional biomarkers improve independently inform predictive power existing model objective multiple recent research endeavor imaging biomarkers derived computed tomography shown promise assessment cardiovascular risk example coronary artery calcium cac score measure extent plaque coronary artery coronary important tool ihd risk stratification although cac scoring strong independent predictor cardiovascular event integration clinical factor e.g. imaging factor e.g. cac score shown significantly improve prediction major cardiac event all-cause mortality compared clinical imaging metric alone study combined metric coronary angiography blood biomarkers high-sensitivity cardiac troponin successfully improve upon current measure cardiovascular risk specialized method apply subset patient already assessed cardiovascular risk alternatively abdominopelvic contain body composition imaging biomarkers atherosclerotic cardiovascular disease hepatic steatosis low muscle mass increased ratio visceral subcutaneous adipose tissue vat/sat abdominal aortic calcification notably million abdominopelvic acquired annually almost twice often scan image heart coronary vessel non-contrasted chest coronary according national hospital ambulatory care survey http million abdominopelvic acquired emergency department visit alone often relation abdominal pain—the common principal reason visiting emergency department comparison roughly million chest performed emergency department visit within abdominopelvic biomarkers could measured routine imaging procedure without resulting additional cost radiation exposure referred opportunistic imaging however current clinical workflow volume imaging well-suited allow practical utilization additional resource required manually extract measurement imaging biomarkers consequently despite potential value cardiovascular risk routinely assessed upon abdominopelvic acquisition thereby missing opportunity early disease detection prevention work developed ihd risk assessment model use automatically measured imaging feature abdominopelvic examination combination patient emr evaluate benefit extracting imaging biomarkers axial slice level third lumbar vertebra addition traditional pce metric also develop ihd risk assessment tool using raw slice image end-to-end manner using deep learning develop method quantitatively ass contribution imaging feature model prediction aggregated tissue level introduce method tissue saliency work finally combine feature derived emr addition slice yielding greatest risk prediction performance interpret individual contribution clinical feature spur research publicly release opportunistic ihd prediction ol3i dataset overall depict opportunistic utilization already-acquired imaging emr data facilitate primary prevention ihd without requiring additional testing radiation cost radiological assessment method study population following stanford university institutional review board approval accordance relevant guideline regulation identified initial cohort 36,354 contrast-enhanced abdominopelvic performed abdominal pain january may individual presented tertiary center emergency department included image 1.0 1.25 axial spacing individual year age older least one documented clinical encounter year prior least year immediately following acquisition image patient data previous medical encounter obtained informed consent waived analysis institutional review board demographic information birthdate sex race/ethnicity along vital sign body mass index bmi international classification disease 10th edition icd10 code current procedural terminology cpt code laboratory result prescription extracted labeled individual icd10 diagnosis code ischemic heart disease i20-i25 follow-up period image acquisition ihd positive code negative icd code found high sensitivity specificity identifying ihd prior study since goal identify new ihd patient may otherwise detected excluded image individual diagnosis ihd prior time image acquisition defined two cut-off period follow-up year year establishing two cohort representing individual either develop ihd follow-up within time frame volume automatically identified slice using previously published convolutional neural network cnn algorithm manually verifying correctness case slice chosen common reference location analysis process select final cohort patient shown supplementary fig excluded image artifact obscured level e.g. spinal instrumentation anatomical variation image e.g. scoliosis precluded assignment single slice level contain slice field view obtained within 6-month window already included image cohort used random sampling stratifying outcome label divide patient dataset training test datasets representing image respectively ihd risk estimation model creation segmentation model given metric manual segmentation correlated cardiovascular risk trained 2.5d u-net cnn perform analysis segmenting region muscle along vat sat abdominopelvic slice total axial slice obtained exclusively training set manually labeled used model tuning evaluation manual segmentation muscle vat sat bone performed semi-automatically coreslicer free online tool using attenuation threshold manual adjustment needed year experience image randomly selected segmentation training validation testing segmentation performance test image determined using segmentation accuracy metric namely dice coefficient root-mean-squared coefficient-of-variation dice coefficient calculated two time ratio intersection ground-truth segmented image mask sum number pixel mask dice score indicates perfect segmentation variation manual automated segmentation approach tissue-wise radiodensity measured hounsfield unit cross-sectional area measured also evaluated input 2.5d network individual axial slice level three different window level w/l setting maximizing tissue contrast w/l setting used included soft tissue window w/l 400/50 bone window w/l 1800/400 custom window w/l 500/50 applying appropriate windowing channel normalized value u-net utilized convolution level two convolutional operator followed rectified linear unit activation followed batch normalization encoder decoder number u-net feature per layer increased quadratically dimension convolutional kernel maximum pooling operator softmax activation used final layer cnn along weighted soft dice loss function account class imbalance amongst segmented tissue u-net hyperparameters previously optimized medical imaging segmentation weighting factor used muscle loss computation network weight randomly initialized using initialization scheme training performed adam optimizer default parameter 0.9 0.999 learning rate schedule included base learning rate 1e−3 learning rate reduced 0.8 every epoch minimum value 1e−8 network nominally trained epoch early stopping criterion minimum change loss 1e−5 patience epoch batch size training validation testing chosen respectively maximizing gpu memory training performed using tensorflow 1.14 nvidia titan gpu used segmentation generated u-net model determined average muscle radiodensity vat/sat cross-sectional area ratio trained model logistic regression using tenfold cross validation select penalty weight model trained using training set predict ihd outcome year using two feature refer segmentation model imaging model trained cnn feature extractor predict risk ihd using single axial slice level using efficientnet-b6 architecture efficientnets designed balance scaling network width depth image size thus producing state-of-the-art result conventional image classification task smaller faster model compared traditionally used feature extractor resnet50 pixel grayscale slice clipped contain value represented unsigned integer replicated thrice produce image resized input network initial efficientnet-b6 model weight obtained pre-trained model optimized imagenet classification performance http final fully-connected layer replaced one corresponding binary outcome model weight fine tuned tuning weight performed cross-entropy objective using random selection training set reserving validation training performed multiple epoch improvement validation loss area receiver operating characteristic auroc observed batch size adam optimizer used default parameter 0.9 0.999 constant learning rate 7e-6 6e-6 5-year cohort respectively model training carried using pytorch 1.1 nvidia titan gpu compared training final layer opposed training model weight using additional image augmentation rotation pixel shifting pixel training using focal loss function assigning higher weight ihd case chose final network architecture training strategy described achieved highest auroc validation stage supplementary table clinical model used data extracted emr produce feature develop predictive model demographic data used age time scan sex initial approach include race/ethnicity feature limited accuracy medical record addition obtaining benefit discrimination performance preliminary result including covariate emr within one year prior image acquisition obtained blood pressure measurement bmi relevant laboratory result total low-density lipoprotein cholesterol high-density lipoprotein cholesterol triglyceride fasting glucose hemoglobin a1c diagnosis icd10 procedure cpt medication atc code multiple clinical encounter vital sign laboratory result combined using exponential weighting average weight inversely proportional difference time data point acquisition image acquisition number time vital sign lab result reported also used feature apart select pce covariates low-density lipoprotein cholesterol high-density lipoprotein cholesterol imputed median imputation imputation strategy used missing value avoid sparsity grouped icd10 cpt medication based underlying ontology namely grouped icd10 code http block cpt category code http level summarize overall burden disease single feature also calculated charlson comorbidity index patient included feature irrespective dose frequency active substance prescribed medication mapped rxnorm subsequently second level anatomical therapeutic code http corresponding therapeutic subgroup furthermore prior training iteratively removed highly correlated feature pearson correlation coefficient 0.5 patient emr represented using 422-dimensional vector final clinical feature used description listed supplementary table predictive model used predicting ihd risk emr feature designed using xgboost optimized gradient-boosting machine learning system gradient boosting ensemble weak learner iteratively constructed greedily adding estimator fit previous residual gradient boosting algorithm perform successfully across wide variety predictive task often outperforming traditional model logistic regression support vector machine chose xgboost robust performance predictive modeling capacity handle missing data gradient boosted method like adaboost lack optimal parameter training model established using ten-fold cross-validation training set fusion model identify potential benefit using imaging feature predictor ihd risk constructed three model fuse imaging clinical data first fusion concatenated feature used pce average muscle radiodensity vat/sat ratio pce segmentation model latter two measurement obtained using automated segmentation model used xgboost classifier predict ihd risk pce segmentation feature second fusion combined risk output efficientnet-b6 model risk output medical record model using stacking logistic regression imaging clinical model third fusion combined risk output imaging clinical segmentation model imaging clinical segmentation model stacking logistic regression classifier fusion case performed hyperparameter search tenfold cross-validation training set summary prediction model approach seen fig clinical model fusion model trained using scikit-learn 0.23 http python 3.6 figure proposed model evaluating risk future ischemic heart disease diagnosis one five year following abdominopelvic computed tomography blue line show source used existing risk assessment model framingham risk score pooled cohort equation pce pce standard tool atherosclerotic cardiovascular disease risk assessment current clinical guideline 10-year risk estimation proposed model axial slice corresponding third lumbar vertebra anatomical level automatically selected volume one model slice automatically segmented extract mean muscle radiodensity hounsfield unit visceral/adipose cross-sectional area ratio feature used alone combination covariates pce form segmentation pce segmentation model alternatively feature automatically extracted slice using convolutional neural network imaging model additional approach prediction model trained feature constructed patient electronic medical record within year prior acquisition clinical model stacked imaging model imaging clinical fusion model segmentation model imaging clinical segmentation model depicted full size image interpretation model performance two baseline model currently employed clinical practice estimate 10-year cardiovascular risk used reference namely pce studied performance directly model risk hard ihd event despite pce including atherosclerotic cardiovascular disease outcome also included baseline given current use clinical practice guideline since several patient missing covariates necessary pce calculation supplementary table value imputed using median imputation allow baseline risk calculation individual study addition examined performance model subpopulation available/missing pce covariates supplementary table attribution analysis aim allowing interpretability fusion model examined contribution individual feature imaging clinical model imaging model developed new tissue saliency interpretation tool described introduction evaluate tissue large contribution final prediction outcome first calculated derivative ihd class score final layer efficientnet-b6 model ihd respect input pixel image ihd using segmentation model pixel assigned specific tissue class particular case corresponded either muscle vat sat body tissue background obtain observed normalized tissue saliency particular tissue =\frac norm saliency particular tissue divided norm total saliency contrast observed saliency value expected tissue saliency define using cardinality observed segmentation =\frac i.e. proportion pixel image belonging tissue compared proportion observed vs. expected tissue saliency across dataset averaging value image assign specific tissue label pixel first obtained binary mask identifying patient body removing background bed using traditional image processing method specific tissue label adipose tissue muscle within body automatically assigned using segmentation cnn tissue within body mask belonging vat sat muscle assigned tissue class pixel considered background overall tissue saliency analysis depicts tissue phenotype contributes towards ihd risk examine relative contribution clinical feature prediction decision determined shapley additive explanation shap value feature individual shap value additive metric feature importance quantify change expected model prediction conditioned feature value word measure much model prediction change given value particular feature used shap value interpret relative contribution clinical feature final model classification output statistical analysis auroc used primary metric compare select model training auroc equivalent c-statistic case binary classification traditionally reported cardiovascular risk assessment literature addition measured area precision recall curve aucpr informative case imbalanced datasets one metric confidence interval obtained using stratified bootstrap method also report sensitivity specificity positive negative predictive value model sample threshold defined using youden index statistical analysis carried using scipy 1.3 comparison auroc value carried using delong method previously validated purpose comparison aucpr value established using stratified bootstrap method observed expected tissue saliency value compared using paired t-tests test performed two-tailed value 0.05 used determine statistical significance result final patient cohort collected dataset image individual least 1-year follow-up subset image individual least 5-years follow-up average interquartile range length follow-up 3.6 2.2 year individual data available emr year scan acquisition obtained 5-year follow-up scan acquisition new ihd diagnosis identified 4.4 25.2 individual sampling performed stratified fashion prevalence training test set equal cohort average standard deviation age time scan dataset 51.7 17.1 year 40.5 exam men additional demographic characteristic cohort along pce covariates metric supplementary table scan performed multi-slice scanner toshiba respectively parameter protocol included tube voltage mode range 70–140 slice thickness 1.00 1·25 respectively tube current setting based bmi mean 424.5 standard deviation soft tissue reconstruction kernel predominantly used additional detail scanner protocol used listed supplementary table slice correctly labeled 99.5 case incorrect case predicted slice away correct location mean standard deviation incorrect localization typically occurred exam additional anatomical coverage scan also including chest lower extremity otherwise automatically selected slice level immediately adjacent level performance model held-out test set reported follows traditional ihd risk assessment model performance pce performed comparably 1-year ihd prediction auroc 0.77 0.74 0.07 aucpr 0.13 0.10 0.05 5-year ihd prediction auroc 0.73 0.71 0.14 aucpr 0.44 0.43 0.79 respectively table roc precision-recall curve pce shown fig compared proposed model supplementary fig sensitivity specificity positive negative predictive value pce two clinically relevant cut-offs shown supplementary table table proposed model performance comparison pooled cohort equation pce framingham risk score measured area receiver operating characteristic auroc precision-recall aucpr curve full size table figure performance proposed imaging clinical fusion model compared pooled cohort equation pce visualized receiver operating characteristic roc curve top row precision recall curve bottom row 1-year 5-year ihd risk modeling shaded line indicate confidence interval dashed line show performance random roc curve prevalence-based classifier precision recall curve simplest baseline area curve auc determined using delong method roc curve using bootstrap method precision-recall curve full size image segmentation model performance example segmentation produced model depicted fig example along quantitative assessment model measured dice score supplementary fig show model reliably label muscle adipose tissue mean standard deviation dice score 0.97 0.03 0.97 0.02 0.96 0.05 muscle sat vat respectively furthermore error computing tissue radiodensity cross-sectional area respectively three segmented tissue figure segmentation tissue saliency sample slice first column shown four individual least 5-years follow-up image acquired corresponding segmentation generated segmentation model second column calculated risk traditional pce contrasted accurate imaging clinical fusion risk saliency imaging model shown overlayed segmentation third column distribution observed aggregated saliency value tissue type relative saliency image versus expected saliency shown tissue 1-year top 5-year bottom risk prediction expected saliency calculated proportion pixel corresponding class image full size image bi-variate predictive model using vat/sat ratio muscle radiodensity feature segmentation model performed inferior pce 1-year ihd risk estimation auroc 0.70 0.02 aucpr 0.08 0.04 5-year cohort model performed comparably auroc 0.68 0.10 aucpr 0.36 0.06 imaging model performance imaging model also achieved comparable performance pce 1-year ihd risk prediction achieved 1-year auroc 0.76 0.89 aucpr 0.11 0.76 showed improved performance 5-year risk prediction comparable auroc 0.78 0.25 yet higher aucpr 0.56 0.048 table model also outperformed segmentation model statistically significant increase 0.06 0.04 0.10 0.005 5-year auroc respectively contribution individual tissue final prediction assessed tissue saliency figure show sample slice segmentation well tissue saliency value superimposed original image figure show distribution observed expected tissue saliency value 1-year follow-up cohort observed/expected tissue saliency ratio 1.71 1.67 1.50 1.15 0.54 tissue muscle vat sat background respectively 5-year follow-up cohort ratio 2.00 1.76 1.75 1.50 0.42 vat tissue muscle sat background respectively ratio higher expected muscle vat sat body tissue lower expected background difference pair observed vs. expected value statistically significant 0.001 clinical model performance clinical model achieved auroc/aucpr 0.80/0.14 0.76/0.51 5-year ihd risk prediction achieving comparable performance pce 1-year prediction auroc 0.08 aucpr 0.70 5-year prediction 0.27 auroc 0.14 aucpr figure show ten feature highest average shap value 5-year ihd risk prediction model majority top feature also identified 1-year follow-up cohort albeit order case traditional cardiovascular risk factor age male sex hypertension-related variable present among top feature addition serum glucose measurement diagnosis renal failure present among top model top feature 1-year model included number time serum glucose measured use diuretic symptom sign involving circulatory respiratory system bmi present among top ten 5-year model impactful feature prediction determined shap value age higher risk older individual shap value individual 5-year risk cohort shown fig figure clinical model feature importance quantified shap shapley additive explanation value top feature training set 5-year risk prediction cohort higher shap value indicate higher expected probability ihd assigned model individual shap value feature highest value individual 5-year risk prediction cohort along risk assigned clinical model pce imaging clinical fusion model risk also shown along outcome full size image fusion model performance performance predictive algorithm combining segmentation metric original pce covariates pce segmentation model comparable pce alone 5-year auroc/aucpr value 0.76 0.83 0.38 0.72 0.40 0.39 respectively thus inclusion average muscle radiodensity vat/sat ratio improve prediction ihd risk using pce covariates performance imaging clinical model depicted fig 5-year ihd risk modeling model showed marked improvement prediction capability compared pce term auroc 0.80 aucpr 0.60 statistically significant increase 0.03 0.003 respectively 0.07 0.16 respectively 1-year ihd risk modeling model higher auroc compared pce 0.81 0.02 similar aucpr imaging clinical segmentation model performed similarly imaging clinical model 1-year ihd prediction statistically significant difference found auroc aucpr ihd prediction compared imaging clinical model statistically significant improvement 0.03 aucpr 0.02 compared imaging clinical model 5-year ihd prediction non-statistically significant improvement 0.01 auroc 0.25 furthermore statistically significant increase auroc aucpr 5-year ihd prediction compared pce case imaging clinical model found performance baseline model proposed model across subpopulation complete/missing pce covariates across different age sex race/ethnicity among patient taking lipid-modifying agent well acute vs. nonacute ihd outcome reported supplementary table discussion study propose automated explainable opportunistic risk assessment method 1-year 5-year ihd risk following contrast-enhanced abdominopelvic using single slice feature quantifying muscle radiodensity body fat conjunction traditional cardiovascular risk factor additional clinical data derived emr model perform comparably better currently used tool ass cardiovascular risk additionally publicly release image corresponding ehr-derived feature 5-year ihd outcome ol3i dataset first large-scale public dataset opportunistic evaluation patient outcome code trained model also made publicly available use biomarkers derived abdominal imaging cardiovascular risk assessment explored past pickhardt extracted univariate metric colonography liver muscle radiodensity abdominal aortic calcification vat/sat ratio combined asymptomatic individual found improvement 2-year cardiovascular event prediction auroc 0.77 compared 0.71 using alone highlighting value imaging biomarkers cardiovascular risk assessment method developed using colonography imaging modality remains underutilized contrast model perform opportunistic risk assessment individual undergo contrast-enhanced abdominopelvic commonly used diagnostic scan wide variety clinical setting thus model may potentially allow opportunity incidental risk assessment ihd moreover current diagnostic scan abdominopelvic generally geared towards addressing primary clinical concern e.g. cause acute abdominal pain model one proposed study could increase diagnostic prognostic value medical image providing risk assessment addition answering primary clinical question etiology patient acute symptom magudia predicted myocardial infarction using population-normalized metric muscle vat sat area z-scores outpatient adult without major cardiovascular oncologic diagnosis undergoing routine abdominal found controlling bmi cardiovascular risk factor vat area associated subsequent infarction risk though approach limited demographic white black individual included patient white finding consistent pce segmentation model suggest aggregate metric alone may sufficient improve prediction clinically relevant baseline alternatively model include individual asian hispanic race ethnicity well improved feature extraction imaging biomarkers clinical feature result improved predictive performance existing clinical model pce shown overestimate risk developing cardiovascular disease contemporary real-world population model used predominantly time-to-event risk assessment developed maximize c-statistic auroc binary classification setting typically used cut-offs defined high sensitivity expense specificity test cohort auroc baseline model comparable prior validation study believe use reporting aucpr considered development ihd risk assessment model shown curve dominate roc dominates precision-recall space prc informative imbalanced classification setting typical ihd risk assessment considering trade-off precision recall model designed high sensitivity also high precision i.e. fraction true positive among identified positive although intent replace role current risk assessment note 5-year ihd risk model outperform pce roc precision-recall space indicates successfully identify individual risk developing ihd higher proportion true positive among identified high risk method seek address model interpretability important barrier potential implementation artificial intelligence medicine though segmentation model high dice score similar published study metric alone combination pce covariates outperform pce knowledge approach first model ihd risk prediction end-to-end manner using image directly opposed metric outperforming radiomics/pce approach 5-year ihd prediction addition treating ihd risk prediction end-to-end imaging problem introduced concept tissue saliency study contribution pixel prediction made imaging model unlike existing widely used pixel-wise attribution method enable qualitative assessment individual image tissue saliency enabled ass contribution group pixel belonging tissue class qualitative quantitative manner expected tissue within body higher amount saliency expected notably vat muscle tissue consistent observation biomarkers quantifying radiodensity area tissue informative ihd risk tissue saliency ratio tissue also higher expected could due liver abdominal aortic calcification trabecular bone radiodensity present slice level explicitly segmented study seen example fig furthermore background pixel provided lower-than-expected negligible proportion saliency upon visualization example background pixel higher saliency typically neighboring body indicates model may using patient habitus feature aggregate tissue saliency provides insight contribution tissue prediction increasing understanding underlying driver prediction better-performing imaging model found evidence including additional clinical feature could improve performance imaging model ehr derived feature leveraged develop improved ihd risk assessment model compared pce result show added value combining imaging-derived feature examined importance individual clinical feature shap value among top predictor feature represent traditional cardiovascular risk factor age male sex hypertension charlson comorbidity index high importance model previously correlated recurrence mortality following acute coronary syndrome well anatomic severity coronary artery disease feature increased serum glucose associated higher risk model may better ass ihd risk diagnosis diabetes alone feature salient among shap analysis similarly use diuretic common treatment hypertension positively associated ihd explainable hypertension well-studied modifiable ihd risk factor finally renal failure also among top ten predictor identified independent risk factor ihd use shap value aid understanding individual feature may affect prediction ihd risk presence well-known risk factor among top predictor raise trust individual attempting scrutinize prediction model shap value tissue saliency could provide clinician mechanism interpret intervene based specific aspect patient history new artificial intelligence application medical imaging continue emerge gain popularity explainability may important factor clinical adoption several potential way model could utilized clinical practice undergoing commonly performed contrast-enhanced abdominopelvic non-ihd indication individual could opportunistically assessed high ihd risk undergo cardiovascular follow-up referred primary care preventive cardiology potential initiation preventive intervention furthermore specific metric automatically calculated could used identify tangible area improvement well used track progress following intervention ultimately model could identify individual high ihd risk may gone otherwise unnoticed goal opportunistic risk assessment finally model could analyze scan already performed housed within picture archiving communication system retrospective identification high ihd risk patient publicly release ol3i dataset comprised image accompanying clinical feature ihd outcome label first publicly available dataset opportunistic imaging best knowledge first multimodal dataset prognostic outcome expect dataset promote research imaging multimodal approach opportunistic risk assessment ihd study limitation data sourced retrospectively single center ihd diagnosis made outside center missed though reported result correspond test set patient used model development confirming potential clinical use model requires prospective evaluation ideally multiple center work lay groundwork external evaluation applicability approach underrepresented population differing race socioeconomic background could analyzed though cohort comprised diverse individual term sex ethnicity supplementary table identified variable across model performance may vary typically disadvantage underrepresented minority found small variation present within patient subpopulation supplementary table motivating study validation cohort identify demographic-specific threshold intervention furthermore include socioeconomic indicator subanalyses factor variation previously detected cardiovascular risk assessment evaluation could also address potential selection bias study selected patient present emergency department abdominal pain contrast-enhanced abdominopelvic scan performed include additional body composition metric waist circumference waist hip ratio weight height ratio may add predictive power traditional risk score routinely measured patient population another limitation biomarkers aortic calcification liver radiodensity may necessarily visualized single slice approach analyzed may explain lack improvement combining segmentation metric pce feature identified study additionally utilized 5-year prediction time point might penalize pce validated 10-year risk assessment however 1-year prediction enable identification high-risk individual study similarly used 5-year window model comparison additionally study ascvd risk pce developed result presented herein meant replace current risk assessment tool rather serve additional tool assessment aid clinical decision making finally 5-year cohort prediction model showed improvement established baseline 1-year ihd risk prediction model able outperform despite exploring variety data sampling alternative loss function improve performance model improved performance 5-year prediction however could provide window opportunity initiate preventive intervention alternatively considerable proportion individual cohort missing laboratory measurement would necessary evaluate pce time scan acquisition indicating cardiovascular risk recently assessed opportunistic approach could used alert referring provider particularly high ihd risk individual prompt evaluation conclusion developed open-sourced framework use artificial intelligence model enable opportunistic risk assessment ihd following abdominopelvic scan drawing multiple data source able produce model perform comparably better currently used clinical risk model currently guide treatment decision individual undergoing cardiovascular risk assessment model automatically integrating existing emr data identify patient increased risk ihd could provide opportunity effective preventive intervention population health level